ArticleProceedings of the National Academy of Sciences of the United States of America2008

In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas.

Kylie D Mason et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.